Screener
Cogent Biosciences, Inc. COGT Operating Lease ROU Assets
Operating Lease ROU Assets at other companies
Other financials
Where this comes from
Reported directly by Cogent Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.
The source filing: Cogent Biosciences, Inc.’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 8:21 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-205170
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Short-term marketable securities | 625,170 | 588,753 |
| Prepaid expenses and other current assets | 11,425 | 9,590 |
| Total current assets | 877,803 | 910,355 |
| Operating lease, right-of-use assets | 17,549 | 18,078 |
| Property and equipment, net | 5,298 | 5,457 |
| Restricted cash | 416 | 416 |
| Other assets | 1,940 | 3,301 |
| Total assets | $903,006 | $937,607 |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Cogent Biosciences, Inc.'s operating lease ROU assets?
- Cogent Biosciences, Inc. (COGT) reported operating lease ROU assets of $17.55M in Q1 2026.
- How has Cogent Biosciences, Inc.'s operating lease ROU assets changed year-over-year?
- Cogent Biosciences, Inc.'s operating lease ROU assets decreased by 10.5% year-over-year, from $19.6M to $17.55M.
- What is the long-term trend for Cogent Biosciences, Inc.'s operating lease ROU assets?
- Over 5 years (2020 to 2025), Cogent Biosciences, Inc.'s operating lease ROU assets has grown at a 31.4% compound annual growth rate (CAGR), from $4.62M to $18.08M.
- What does operating lease ROU assets mean?
- Right-of-use assets representing the lessee's right to use leased property over the lease term under ASC 842 operating lease classification.
Ask your AI about Cogent Biosciences, Inc.'s operating lease rou assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude